The key to making a colloidal silver sinusitis treatment effective is three-fold:
All three of these criteria are essential to a successful outcome.
It is important that the initial concentration of the anticrobial agent be high enough so that dilution at the site would still provide silver densities over the infected tissues at greater than 5 micro-grams per milliliter.
Minimum bactericidal concentration (MBC) testing has shown that this is critical to ensure a sufficient attenuation of the pathogen. Due to the bonding of the silver with interstitial ions, muco-polysaccharides (mucus) and proteins, the initial concentration of the active agent (silver colloid) needs to be greater than 30 ppm (parts per million).
Typical concentrations of simple ionic or colloidal silvers are 8 to 15 ppm and this is insufficient because they are not capable of killing enough pathogens.
Some colloids boast concentrations of 250 to 500 ppm. These high silver concentration concoctions have bound the silver to a carrier such as a protein or polysaccharide to hold more silver in suspension.
The problem with this is that the process of binding the silver before it even gets exposed to the pathogens reduces the antimicrobial nature of the silver thousands of times.
Further and even worse is the fact that you are taking 10 to 20 times the dose yet achieving 100 times less effectiveness. These “mild silver proteins” or compounded silver hydrosol concoctions are not what the sinusitis-suffering community should be using.
An enhanced pure silver colloid offers the best killing power and lowest silver dose.
Laboratory and clinical testing has demonstrated this for years.
The next critical aspect of the therapy is to apply the liquid agent directly to the infected tissue. This can be done by a nasal wash or by aerosol administration intra-nasally.
As the sinus condition improves and the swelling and inflammation subsides, access to deeper nasal recesses is achieved. Using a nasal flushing device such as a neti-pot is helpful, however, for convenience, clinical studies have indicated that administration with a simple nasal spray bottle is also very effective.
It is recommended that administration of the active agent be with a neti-pot in the morning and evening. This is then supplemented with nasal administration from the spray bottle throughout the day.
Remember that it is important to use the appropriate liquid agent in a cleaned, rinsed neti pot and this will be covered later in the text.
The final and third important aspect of the treatment is to repeat the application of the liquid agent regularly enough to maintain the presence in the region. This is particularly important as the bacteria when left untreated can double every 20 minutes.
If you achieve a reduction of the bacterial load of 4:1 in-situ with a spray of the antimicrobial agent, but do not spray again for a couple of hours, the bacterial load will have rebounded past the point at which it was previously. This results in a no net attenuation of the infection.
Re-application of the anti-microbial agent every 20 minutes ensures that the user gets ahead of the bacterial replication and achieves a successful treatment.
If you spray every 20 to 30 minutes, the effects of the reduction will be cumulative and a progressive reduction in the bacterial load will be accomplished.
Since normal mucosal flow is on the order of one liter per day, shortly after spraying the colloid in the nasal area, it will be bound to muco-polysaccharides and flushed from the region. The replenishment of active agent to the region every 20 to 30 minutes throughout the day is necessary for the success of this therapy.